Capital Analysts LLC Portfolio holdings
Capital Analysts is a Lincoln Investment company that provides a ready-made wealth management platform to independent financial professionals who serve affluent clients. Capital Analysts dates from 2012 and belongs to Lincoln Investment Capital Holdings; Lincoln Investment Planning, a brokerage and advisory firm under the same ownership, handles brokerage services for it and its advisors. Those advisors work across the United States as independent contractors, not employees. Their clients include individuals, high net worth individuals, trusts, foundations, businesses and charities, and Capital Analysts also offers its institutional advisory services to other advisers and trust companies. The portfolios it builds aim to be diversified and rest on asset allocation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$24.6M |
| 2 |
Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF
GPIX
|
+$16.4M |
| 3 |
Fidelity Total Bond ETF
FBND
|
+$16.1M |
| 4 |
iShares Systematic Alternatives Active ETF
IALT
|
+$16M |
| 5 |
iShares Core Universal USD Bond ETF
IUSB
|
+$11.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$7.72M |
| 2 |
Citigroup
C
|
+$7.28M |
| 3 |
iShares Gold Trust
IAU
|
+$6.25M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$6.23M |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$6.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 76.75% |
| 2 | Technology | 5.6% |
| 3 | Financials | 4.52% |
| 4 | Industrials | 2.67% |
| 5 | Healthcare | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1426
SoFi Technologies
SOFI
$21.9B
| $4K | ﹤0.01% |
240
| – | – |
2025 Q1
5 quarters
|
|
1427
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$18.1B
| $4K | ﹤0.01% |
76
| – | – |
2023 Q3
11 quarters
|
|
1428
Cohen & Steers Infrastructure Fund
UTF
$2.9B
| $4K | ﹤0.01% |
136
-54
| -28% | -$1.45K |
2025 Q1
5 quarters
|
|
1429
Zimmer Biomet
ZBH
$20.4B
| $4K | ﹤0.01% |
44
| – | – |
2021 Q1
21 quarters
|
|
1430
iShares Ethereum Trust ETF
ETHA
$6.4B
| $4K | ﹤0.01% |
105
| – | – |
2026 Q1
1 quarter
|
|
1431
Ralliant Corp
RAL
$7.85B
| $4K | ﹤0.01% |
50
| – | – |
2025 Q2
4 quarters
|
|
1432
DoubleLine Securitized Credit ETF
DSCO
$242M
| $4K | ﹤0.01% |
+171
| New | +$4.25K |
2026 Q2
0 quarters
|
|
1433
Alvotech
ALVO
$1.71B
| $3K | ﹤0.01% |
932
| – | – |
2025 Q1
5 quarters
|
|
1434
AB InBev
BUD
$167B
| $3K | ﹤0.01% |
33
| – | – |
2023 Q4
10 quarters
|
|
1435
CRISPR Therapeutics
CRSP
$4.91B
| $3K | ﹤0.01% |
49
| – | – |
2024 Q1
9 quarters
|
|
1436
Datadog
DDOG
$65.1B
| $3K | ﹤0.01% |
10
+2
| +25% | +$372 |
2024 Q3
7 quarters
|
|
1437
Strive US Energy ETF
DRLL
$305M
| $3K | ﹤0.01% |
94
+1
| +1% | +$36 |
2025 Q1
5 quarters
|
|
1438
Elastic
ESTC
$9.43B
| $3K | ﹤0.01% |
58
| – | – |
2024 Q3
7 quarters
|
|
1439
Liberty Media Corporation Series C Common Stock
FWONK
$26.7B
| $3K | ﹤0.01% |
34
| – | – |
2021 Q3
19 quarters
|
|
1440
nVent Electric
NVT
$18.4B
| $3K | ﹤0.01% |
15
| – | – |
2024 Q2
8 quarters
|
|
1441
O'Reilly Automotive
ORLY
$72B
| $3K | ﹤0.01% |
35
-35
| -50% | -$3.19K |
2021 Q1
21 quarters
|
|
1442
Avita Medical
RCEL
$552M
| $3K | ﹤0.01% |
652
| – | – |
2021 Q1
21 quarters
|
|
1443
VanEck Retail ETF
RTH
$259M
| $3K | ﹤0.01% |
10
| – | – |
2023 Q3
11 quarters
|
|
1444
SiriusXM
SIRI
$11B
| $3K | ﹤0.01% |
104
+1
| +1% | +$27 |
2025 Q3
3 quarters
|
|
1445
State Street SPDR Portfolio Long Term Treasury Index ETF
SPTL
$11.7B
| $3K | ﹤0.01% |
112
+1
| +0.9% | +$26 |
2019 Q2
28 quarters
|
|
1446
Scorpio Tankers
STNG
$4.12B
| $3K | ﹤0.01% |
48
| – | – |
2024 Q3
7 quarters
|
|
1447
Teekay Tankers
TNK
$2.99B
| $3K | ﹤0.01% |
44
| – | – |
2024 Q3
7 quarters
|
|
1448
Tetra Tech
TTEK
$10.5B
| $3K | ﹤0.01% |
100
| – | – |
2025 Q1
5 quarters
|
|
1449
Yum China
YUMC
$16.7B
| $3K | ﹤0.01% |
69
| – | – |
2024 Q3
7 quarters
|
|
1450
Astera Labs
ALAB
$38.2B
| $3K | ﹤0.01% |
+6
| New | +$1.59K |
2026 Q2
0 quarters
|
|
Similar funds
Capital Analysts LLC's Q2 2026 Portfolio in Review
As of Q2 2026, Capital Analysts LLC held 1,612 positions worth $4.34B, up 14% from $3.81B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capital Analysts LLC deployed $223M of net new capital in Q2 2026, opening 75 new positions and adding to 544 existing holdings. Its largest new stake was iShares Systematic Alternatives Active ETF: 571,327 shares worth $16M.
By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, up from 75% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Zoetis, an estimated $7.72M trimmed.
- Capital Analysts LLC's largest Q2 2026 buy was iShares Systematic Alternatives Active ETF: 571,327 shares worth $16M.
- Capital Analysts LLC added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $24.6M increase.
- Capital Analysts LLC's biggest Q2 2026 reduction was Zoetis, cutting an estimated $7.72M.
- Capital Analysts LLC fully exited Hershey in Q2 2026, selling an estimated $113K.
- Capital Analysts LLC's ten largest holdings make up 30% of its $4.34B portfolio in Q2 2026.
- Capital Analysts LLC opened 75 new positions and closed 76 in Q2 2026.
- Capital Analysts LLC's portfolio value rose 14% quarter-over-quarter to $4.34B.
Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.